Regan Whitmer-Johnson Bergmark, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rhinitis | 22 | 2023 | 747 | 3.580 |
Why?
|
Sinusitis | 24 | 2023 | 990 | 3.490 |
Why?
|
Otolaryngology | 12 | 2024 | 693 | 2.920 |
Why?
|
Head and Neck Neoplasms | 8 | 2024 | 2894 | 1.210 |
Why?
|
Nasal Polyps | 8 | 2023 | 395 | 1.090 |
Why?
|
Insurance Coverage | 8 | 2024 | 1935 | 0.940 |
Why?
|
Tonsillectomy | 2 | 2024 | 277 | 0.870 |
Why?
|
Healthcare Disparities | 9 | 2024 | 3354 | 0.810 |
Why?
|
Nasal Obstruction | 4 | 2018 | 160 | 0.790 |
Why?
|
Surgical Procedures, Operative | 4 | 2022 | 1923 | 0.780 |
Why?
|
Physicians, Women | 4 | 2021 | 510 | 0.760 |
Why?
|
Otorhinolaryngologic Diseases | 2 | 2024 | 97 | 0.730 |
Why?
|
Ambulatory Surgical Procedures | 3 | 2022 | 463 | 0.710 |
Why?
|
Specialties, Surgical | 2 | 2022 | 389 | 0.710 |
Why?
|
Endolymphatic Sac | 1 | 2020 | 49 | 0.700 |
Why?
|
Emergency Service, Hospital | 7 | 2024 | 7865 | 0.660 |
Why?
|
Hemostasis, Surgical | 1 | 2019 | 126 | 0.650 |
Why?
|
Otologic Surgical Procedures | 1 | 2020 | 150 | 0.650 |
Why?
|
Meniere Disease | 1 | 2020 | 164 | 0.640 |
Why?
|
Qualitative Research | 6 | 2024 | 3024 | 0.640 |
Why?
|
Wound Closure Techniques | 1 | 2019 | 87 | 0.630 |
Why?
|
Insurance, Health | 5 | 2024 | 2493 | 0.620 |
Why?
|
Turbinates | 1 | 2018 | 65 | 0.590 |
Why?
|
Certification | 1 | 2021 | 418 | 0.590 |
Why?
|
Triage | 1 | 2024 | 985 | 0.570 |
Why?
|
Publications | 1 | 2019 | 194 | 0.570 |
Why?
|
Chronic Disease | 19 | 2023 | 9319 | 0.560 |
Why?
|
Reoperation | 3 | 2024 | 4303 | 0.540 |
Why?
|
Authorship | 1 | 2019 | 284 | 0.540 |
Why?
|
Demography | 1 | 2021 | 1641 | 0.530 |
Why?
|
Risk Adjustment | 1 | 2020 | 601 | 0.530 |
Why?
|
Thyroid Diseases | 1 | 2019 | 386 | 0.530 |
Why?
|
Cross-Sectional Studies | 26 | 2023 | 26071 | 0.510 |
Why?
|
Asthma, Aspirin-Induced | 3 | 2023 | 202 | 0.500 |
Why?
|
Hematoma | 1 | 2019 | 763 | 0.480 |
Why?
|
Social Class | 2 | 2021 | 1993 | 0.470 |
Why?
|
Pneumonia | 2 | 2023 | 2142 | 0.460 |
Why?
|
Automobile Driving | 1 | 2019 | 441 | 0.450 |
Why?
|
Thyroidectomy | 1 | 2019 | 908 | 0.450 |
Why?
|
Internship and Residency | 3 | 2023 | 5885 | 0.440 |
Why?
|
Inpatients | 2 | 2023 | 2545 | 0.440 |
Why?
|
Patient Acceptance of Health Care | 3 | 2023 | 3200 | 0.430 |
Why?
|
United States | 34 | 2024 | 72339 | 0.420 |
Why?
|
Health Services Accessibility | 6 | 2022 | 5425 | 0.420 |
Why?
|
Patient Readmission | 3 | 2024 | 3265 | 0.420 |
Why?
|
Paranasal Sinuses | 3 | 2020 | 265 | 0.420 |
Why?
|
Humans | 104 | 2024 | 761208 | 0.410 |
Why?
|
Hypopharyngeal Neoplasms | 1 | 2012 | 51 | 0.400 |
Why?
|
Income | 4 | 2024 | 1869 | 0.390 |
Why?
|
Primary Health Care | 3 | 2017 | 4678 | 0.380 |
Why?
|
Efficiency | 3 | 2020 | 476 | 0.380 |
Why?
|
Referral and Consultation | 1 | 2024 | 3608 | 0.370 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2011 | 134 | 0.350 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2021 | 4021 | 0.350 |
Why?
|
Socioeconomic Factors | 9 | 2024 | 7804 | 0.330 |
Why?
|
Rheumatic Heart Disease | 1 | 2010 | 163 | 0.330 |
Why?
|
Early Detection of Cancer | 1 | 2024 | 3198 | 0.330 |
Why?
|
Acute Disease | 6 | 2017 | 7226 | 0.320 |
Why?
|
Liposarcoma | 1 | 2012 | 289 | 0.320 |
Why?
|
Air Pollution | 1 | 2023 | 2351 | 0.320 |
Why?
|
Travel | 2 | 2020 | 796 | 0.320 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 3 | 2024 | 324 | 0.320 |
Why?
|
Pandemics | 10 | 2022 | 8663 | 0.320 |
Why?
|
Pharyngitis | 1 | 2010 | 220 | 0.320 |
Why?
|
Climate Change | 3 | 2024 | 498 | 0.310 |
Why?
|
Vagus Nerve | 1 | 2011 | 458 | 0.310 |
Why?
|
Cultural Diversity | 2 | 2023 | 369 | 0.310 |
Why?
|
Periodicals as Topic | 1 | 2019 | 1463 | 0.310 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1789 | 0.300 |
Why?
|
Medicare | 7 | 2021 | 6773 | 0.290 |
Why?
|
Disease Management | 1 | 2018 | 2507 | 0.290 |
Why?
|
Male | 51 | 2024 | 360693 | 0.290 |
Why?
|
Female | 53 | 2024 | 392544 | 0.280 |
Why?
|
Retrospective Studies | 26 | 2024 | 80674 | 0.280 |
Why?
|
Asthma | 4 | 2020 | 6230 | 0.280 |
Why?
|
Ambulatory Care | 2 | 2015 | 2770 | 0.280 |
Why?
|
Endoscopy | 5 | 2020 | 1852 | 0.270 |
Why?
|
General Surgery | 4 | 2022 | 1693 | 0.270 |
Why?
|
Delivery of Health Care | 5 | 2024 | 5333 | 0.270 |
Why?
|
Streptococcal Infections | 1 | 2010 | 617 | 0.260 |
Why?
|
Neurilemmoma | 1 | 2011 | 523 | 0.260 |
Why?
|
Sleep | 1 | 2021 | 4759 | 0.250 |
Why?
|
Parents | 1 | 2019 | 3564 | 0.250 |
Why?
|
Morbidity | 2 | 2020 | 1751 | 0.240 |
Why?
|
Health Services | 2 | 2016 | 750 | 0.240 |
Why?
|
Office Visits | 2 | 2022 | 593 | 0.240 |
Why?
|
Adult | 31 | 2024 | 221119 | 0.230 |
Why?
|
Anti-Bacterial Agents | 4 | 2018 | 7407 | 0.230 |
Why?
|
Hypersensitivity | 2 | 2024 | 1167 | 0.230 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 84 | 0.220 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.220 |
Why?
|
Middle Aged | 34 | 2024 | 220853 | 0.220 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 174 | 0.210 |
Why?
|
Poverty | 3 | 2021 | 2691 | 0.210 |
Why?
|
Attitude of Health Personnel | 2 | 2022 | 3885 | 0.210 |
Why?
|
Organizations | 1 | 2024 | 172 | 0.210 |
Why?
|
Florida | 1 | 2024 | 429 | 0.210 |
Why?
|
Medicaid | 6 | 2024 | 2813 | 0.210 |
Why?
|
Multipotent Stem Cells | 1 | 2024 | 200 | 0.210 |
Why?
|
Physicians | 1 | 2020 | 4584 | 0.200 |
Why?
|
Cell Adhesion Molecules | 2 | 2019 | 1603 | 0.200 |
Why?
|
Emigrants and Immigrants | 1 | 2008 | 544 | 0.200 |
Why?
|
New York | 1 | 2024 | 875 | 0.190 |
Why?
|
Sex Factors | 6 | 2021 | 10553 | 0.190 |
Why?
|
Faculty, Medical | 2 | 2021 | 1205 | 0.190 |
Why?
|
Physical Examination | 2 | 2019 | 1255 | 0.180 |
Why?
|
Medical Staff | 1 | 2021 | 40 | 0.180 |
Why?
|
Granuloma, Plasma Cell | 1 | 2021 | 80 | 0.180 |
Why?
|
Interviews as Topic | 2 | 2024 | 2697 | 0.180 |
Why?
|
Length of Stay | 4 | 2023 | 6417 | 0.180 |
Why?
|
Educational Status | 2 | 2021 | 2510 | 0.180 |
Why?
|
Fee Schedules | 1 | 2020 | 87 | 0.170 |
Why?
|
Gentamicins | 1 | 2020 | 244 | 0.170 |
Why?
|
Free Tissue Flaps | 1 | 2024 | 331 | 0.170 |
Why?
|
Medically Uninsured | 2 | 2024 | 834 | 0.160 |
Why?
|
Gross Domestic Product | 1 | 2019 | 77 | 0.160 |
Why?
|
Specialty Boards | 1 | 2021 | 235 | 0.160 |
Why?
|
Ibuprofen | 1 | 2021 | 229 | 0.160 |
Why?
|
Unemployment | 1 | 2021 | 210 | 0.160 |
Why?
|
Infant Care | 1 | 2020 | 180 | 0.160 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2021 | 290 | 0.160 |
Why?
|
Geography | 1 | 2021 | 652 | 0.160 |
Why?
|
Diverticulitis | 1 | 2021 | 185 | 0.160 |
Why?
|
Th2 Cells | 1 | 2024 | 1071 | 0.160 |
Why?
|
Heart Failure | 1 | 2023 | 11701 | 0.160 |
Why?
|
Anesthetics, Inhalation | 1 | 2023 | 573 | 0.160 |
Why?
|
Mucociliary Clearance | 1 | 2018 | 80 | 0.150 |
Why?
|
Cryopreservation | 1 | 2023 | 728 | 0.150 |
Why?
|
Aspirin | 4 | 2023 | 3129 | 0.150 |
Why?
|
Hospitals | 2 | 2023 | 3881 | 0.150 |
Why?
|
Health Care Costs | 2 | 2022 | 3239 | 0.150 |
Why?
|
Facial Transplantation | 1 | 2020 | 222 | 0.150 |
Why?
|
Cosmetic Techniques | 1 | 2019 | 147 | 0.140 |
Why?
|
Emergency Treatment | 1 | 2021 | 495 | 0.140 |
Why?
|
Absenteeism | 1 | 2018 | 247 | 0.140 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2020 | 385 | 0.140 |
Why?
|
Epistaxis | 1 | 2017 | 112 | 0.140 |
Why?
|
Rhinoplasty | 1 | 2020 | 238 | 0.140 |
Why?
|
Academic Medical Centers | 2 | 2024 | 2756 | 0.130 |
Why?
|
Hemostatic Techniques | 1 | 2017 | 111 | 0.130 |
Why?
|
Dental Care | 1 | 2019 | 282 | 0.130 |
Why?
|
Health Services Research | 2 | 2022 | 1807 | 0.130 |
Why?
|
Hypertrophy | 1 | 2018 | 558 | 0.130 |
Why?
|
Mast Cells | 1 | 2023 | 1392 | 0.130 |
Why?
|
Career Mobility | 1 | 2018 | 259 | 0.130 |
Why?
|
Child, Preschool | 5 | 2024 | 42224 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 4014 | 0.130 |
Why?
|
Bibliometrics | 1 | 2019 | 352 | 0.130 |
Why?
|
Craniotomy | 1 | 2020 | 741 | 0.130 |
Why?
|
Facial Pain | 1 | 2016 | 120 | 0.130 |
Why?
|
SEER Program | 1 | 2020 | 1453 | 0.120 |
Why?
|
Patients | 1 | 2022 | 906 | 0.120 |
Why?
|
Odds Ratio | 3 | 2018 | 9652 | 0.120 |
Why?
|
Reimbursement, Incentive | 1 | 2020 | 542 | 0.120 |
Why?
|
Burnout, Professional | 1 | 2024 | 703 | 0.120 |
Why?
|
Aged | 20 | 2024 | 169288 | 0.120 |
Why?
|
Maternal Health Services | 1 | 2020 | 460 | 0.120 |
Why?
|
Neck | 1 | 2019 | 734 | 0.120 |
Why?
|
Adolescent | 6 | 2024 | 88298 | 0.120 |
Why?
|
Neoplasms | 1 | 2024 | 22140 | 0.120 |
Why?
|
Health Resources | 1 | 2021 | 934 | 0.120 |
Why?
|
Physical Therapy Modalities | 1 | 2018 | 531 | 0.120 |
Why?
|
Attitude | 1 | 2019 | 771 | 0.120 |
Why?
|
Reimbursement Mechanisms | 1 | 2020 | 667 | 0.120 |
Why?
|
Mouth Neoplasms | 1 | 2019 | 596 | 0.110 |
Why?
|
Child | 7 | 2024 | 80152 | 0.110 |
Why?
|
Databases, Factual | 3 | 2024 | 7966 | 0.110 |
Why?
|
Prosthesis Implantation | 1 | 2018 | 590 | 0.110 |
Why?
|
Postoperative Care | 1 | 2020 | 1468 | 0.110 |
Why?
|
Accidents, Traffic | 1 | 2019 | 816 | 0.110 |
Why?
|
Risk-Taking | 1 | 2019 | 1038 | 0.110 |
Why?
|
Nasal Septum | 1 | 2014 | 130 | 0.110 |
Why?
|
Quality of Life | 7 | 2024 | 13367 | 0.110 |
Why?
|
Mexico | 2 | 2021 | 757 | 0.110 |
Why?
|
Biomedical Research | 2 | 2019 | 3434 | 0.100 |
Why?
|
Interleukin-5 | 2 | 2023 | 266 | 0.100 |
Why?
|
Health Personnel | 2 | 2023 | 3337 | 0.100 |
Why?
|
Surgery, Plastic | 1 | 2019 | 640 | 0.100 |
Why?
|
Occupational Diseases | 1 | 2021 | 1490 | 0.100 |
Why?
|
Hospital Mortality | 2 | 2024 | 5295 | 0.100 |
Why?
|
Anti-Asthmatic Agents | 1 | 2017 | 573 | 0.100 |
Why?
|
Carcinoma, Merkel Cell | 1 | 2016 | 328 | 0.100 |
Why?
|
Adrenal Cortex Hormones | 2 | 2018 | 1878 | 0.100 |
Why?
|
Activities of Daily Living | 1 | 2021 | 2420 | 0.100 |
Why?
|
Language | 1 | 2021 | 1539 | 0.100 |
Why?
|
Pain, Postoperative | 2 | 2021 | 1741 | 0.100 |
Why?
|
Propensity Score | 1 | 2019 | 1916 | 0.100 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2016 | 732 | 0.100 |
Why?
|
Anesthesiology | 1 | 2022 | 1122 | 0.100 |
Why?
|
Meningioma | 1 | 2020 | 1216 | 0.090 |
Why?
|
Malaria, Cerebral | 1 | 2012 | 136 | 0.090 |
Why?
|
Health Surveys | 2 | 2021 | 4037 | 0.090 |
Why?
|
Health Care Surveys | 2 | 2016 | 2425 | 0.090 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 2011 | 64 | 0.090 |
Why?
|
Neoplasm Staging | 3 | 2021 | 11119 | 0.090 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2021 | 1186 | 0.090 |
Why?
|
Skilled Nursing Facilities | 1 | 2015 | 400 | 0.090 |
Why?
|
Interleukin-13 | 2 | 2023 | 392 | 0.090 |
Why?
|
Anesthesia | 1 | 2022 | 1591 | 0.090 |
Why?
|
Drainage | 1 | 2016 | 1157 | 0.090 |
Why?
|
Education, Medical, Graduate | 1 | 2023 | 2374 | 0.090 |
Why?
|
Forecasting | 1 | 2019 | 2928 | 0.090 |
Why?
|
Postoperative Complications | 3 | 2024 | 15637 | 0.090 |
Why?
|
Leadership | 1 | 2019 | 1385 | 0.080 |
Why?
|
Prognosis | 4 | 2024 | 29687 | 0.080 |
Why?
|
Drug Prescriptions | 1 | 2018 | 1668 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4574 | 0.080 |
Why?
|
Prostatic Neoplasms | 2 | 2021 | 11101 | 0.080 |
Why?
|
Scalp | 1 | 2011 | 389 | 0.080 |
Why?
|
Comorbidity | 2 | 2020 | 10516 | 0.080 |
Why?
|
Registries | 1 | 2024 | 8247 | 0.070 |
Why?
|
Continuity of Patient Care | 1 | 2015 | 1069 | 0.070 |
Why?
|
Mass Screening | 1 | 2024 | 5426 | 0.070 |
Why?
|
Prospective Studies | 8 | 2021 | 54435 | 0.070 |
Why?
|
Young Adult | 4 | 2019 | 59221 | 0.070 |
Why?
|
Age Factors | 2 | 2021 | 18384 | 0.070 |
Why?
|
Depression | 2 | 2017 | 8132 | 0.070 |
Why?
|
Hospitalization | 2 | 2024 | 10707 | 0.070 |
Why?
|
Survival Rate | 1 | 2021 | 12728 | 0.070 |
Why?
|
Risk Factors | 8 | 2021 | 74239 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2021 | 12052 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15841 | 0.070 |
Why?
|
Tanzania | 1 | 2010 | 1390 | 0.070 |
Why?
|
Pain Measurement | 1 | 2016 | 3549 | 0.060 |
Why?
|
Treatment Outcome | 4 | 2020 | 64681 | 0.060 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9187 | 0.060 |
Why?
|
Quality Improvement | 1 | 2021 | 3808 | 0.060 |
Why?
|
Smoking Cessation | 1 | 2017 | 2056 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2021 | 4487 | 0.060 |
Why?
|
Colorectal Neoplasms | 1 | 2024 | 6919 | 0.060 |
Why?
|
Infant | 2 | 2024 | 36169 | 0.060 |
Why?
|
California | 1 | 2008 | 1431 | 0.060 |
Why?
|
Skin Neoplasms | 2 | 2016 | 5809 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2022 | 4822 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3051 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2022 | 3093 | 0.060 |
Why?
|
Malaria, Falciparum | 1 | 2012 | 1076 | 0.060 |
Why?
|
Steam | 1 | 2023 | 32 | 0.060 |
Why?
|
Greenhouse Effect | 1 | 2023 | 31 | 0.060 |
Why?
|
Nitric Oxide | 1 | 2012 | 2136 | 0.060 |
Why?
|
Antibody-Producing Cells | 1 | 2023 | 140 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2018 | 10218 | 0.050 |
Why?
|
Health Status | 1 | 2016 | 4077 | 0.050 |
Why?
|
Developing Countries | 1 | 2016 | 2863 | 0.050 |
Why?
|
Immunologic Factors | 1 | 2012 | 1589 | 0.050 |
Why?
|
Anti-Inflammatory Agents | 1 | 2012 | 1812 | 0.050 |
Why?
|
Cohort Studies | 2 | 2024 | 41496 | 0.050 |
Why?
|
Muromonab-CD3 | 1 | 2022 | 104 | 0.050 |
Why?
|
Health Expenditures | 1 | 2015 | 2362 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3805 | 0.050 |
Why?
|
Computer Literacy | 1 | 2022 | 44 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 20119 | 0.050 |
Why?
|
Logistic Models | 3 | 2022 | 13249 | 0.050 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2023 | 456 | 0.050 |
Why?
|
Salaries and Fringe Benefits | 1 | 2024 | 256 | 0.050 |
Why?
|
Cuba | 1 | 2021 | 48 | 0.050 |
Why?
|
Central America | 1 | 2021 | 69 | 0.050 |
Why?
|
Epithelial Cells | 2 | 2023 | 3671 | 0.050 |
Why?
|
Administration, Intranasal | 1 | 2022 | 476 | 0.050 |
Why?
|
South America | 1 | 2021 | 180 | 0.050 |
Why?
|
New Jersey | 1 | 2021 | 295 | 0.040 |
Why?
|
Research Subjects | 1 | 2022 | 249 | 0.040 |
Why?
|
Smoking | 1 | 2017 | 9055 | 0.040 |
Why?
|
Relative Value Scales | 1 | 2020 | 84 | 0.040 |
Why?
|
Puerto Rico | 1 | 2021 | 378 | 0.040 |
Why?
|
Diagnosis, Differential | 2 | 2012 | 12976 | 0.040 |
Why?
|
Adenoidectomy | 1 | 2021 | 167 | 0.040 |
Why?
|
Carbon Dioxide | 1 | 2023 | 1147 | 0.040 |
Why?
|
Receptor, Insulin | 1 | 2023 | 836 | 0.040 |
Why?
|
Interleukin-4 | 1 | 2023 | 1154 | 0.040 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2021 | 242 | 0.040 |
Why?
|
Nasopharynx | 1 | 2021 | 400 | 0.040 |
Why?
|
Cytokines | 2 | 2024 | 7386 | 0.040 |
Why?
|
Self Report | 2 | 2021 | 3727 | 0.040 |
Why?
|
Dilatation | 1 | 2020 | 307 | 0.040 |
Why?
|
New York City | 1 | 2021 | 730 | 0.040 |
Why?
|
Telephone | 1 | 2022 | 624 | 0.040 |
Why?
|
Risk Assessment | 1 | 2019 | 24021 | 0.040 |
Why?
|
Proportional Hazards Models | 2 | 2024 | 12474 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5694 | 0.040 |
Why?
|
Cell Proliferation | 2 | 2023 | 10422 | 0.040 |
Why?
|
Sneezing | 1 | 2016 | 17 | 0.040 |
Why?
|
Postoperative Hemorrhage | 1 | 2021 | 416 | 0.030 |
Why?
|
Gadolinium | 1 | 2021 | 961 | 0.030 |
Why?
|
Colectomy | 1 | 2021 | 686 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2008 | 3453 | 0.030 |
Why?
|
Uncertainty | 1 | 2021 | 752 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2023 | 2011 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2021 | 706 | 0.030 |
Why?
|
Pakistan | 1 | 2016 | 292 | 0.030 |
Why?
|
History, 21st Century | 1 | 2021 | 1567 | 0.030 |
Why?
|
Hospitals, University | 1 | 2016 | 565 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2024 | 2092 | 0.030 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 934 | 0.030 |
Why?
|
Bangladesh | 1 | 2016 | 732 | 0.030 |
Why?
|
Prostate | 1 | 2021 | 1772 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2021 | 2024 | 0.030 |
Why?
|
Perception | 1 | 2019 | 1198 | 0.030 |
Why?
|
Breast | 1 | 2021 | 1964 | 0.030 |
Why?
|
Emergency Medical Services | 1 | 2024 | 1920 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2023 | 2451 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2019 | 1723 | 0.020 |
Why?
|
Disabled Persons | 1 | 2021 | 1224 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2020 | 4822 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2023 | 3594 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2014 | 20588 | 0.020 |
Why?
|
Meningeal Neoplasms | 1 | 2020 | 1246 | 0.020 |
Why?
|
Linear Models | 1 | 2021 | 5869 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2021 | 26199 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3803 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2021 | 2640 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3092 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2012 | 628 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2022 | 3691 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2012 | 1159 | 0.020 |
Why?
|
India | 1 | 2016 | 2287 | 0.020 |
Why?
|
Phenotype | 2 | 2017 | 16575 | 0.020 |
Why?
|
Pregnancy | 2 | 2022 | 29893 | 0.020 |
Why?
|
Massachusetts | 1 | 2022 | 8837 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6345 | 0.020 |
Why?
|
Public Health | 1 | 2022 | 2672 | 0.020 |
Why?
|
Contrast Media | 1 | 2021 | 5311 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2024 | 18926 | 0.020 |
Why?
|
Patient Discharge | 1 | 2021 | 3441 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1401 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8642 | 0.020 |
Why?
|
Uganda | 1 | 2012 | 1332 | 0.020 |
Why?
|
Mental Health | 1 | 2021 | 3251 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2024 | 11509 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2019 | 4027 | 0.020 |
Why?
|
Mice | 2 | 2024 | 81326 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 39957 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2016 | 3461 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58952 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14675 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 22174 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10759 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21365 | 0.010 |
Why?
|
Animals | 2 | 2024 | 168079 | 0.010 |
Why?
|
Signal Transduction | 1 | 2023 | 23416 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13511 | 0.010 |
Why?
|
Biopsy | 1 | 2011 | 6781 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15721 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39126 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36415 | 0.010 |
Why?
|